Journals / Acta Medica / 2020 / Cilt: 51 - Sayı: 1

F18-FDG Cardiac PET/CT: An Alternative Tool for Myocardial Viability Determination Prior to Coronary Revascularization Decision in Severe Ventricular Dysfunction

Pages
21–31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Key words: Miocardial viability, FDG-PET (CT), CABG, lower left ventrikular ejection fraction, preoperative surgery endication decision.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of our study was to evaluate clinical value and accuracy of Fludeoxyglucose Cardiac Positron Emission Tomography Computerized Tomography as an alternative tool for myocardial viability determination prior to coronary revascularization decision in lower left ventricular ejection fraction patients.
📊
Key Findings & Data:Materials and Methods: Between the dates of 01.01.2010 and 10.07.2019, 191 consecutive patients (mean age 64±9.1 years) underwent coronary artery bypass graft operations with severe left ventricular ejection fraction dysfunction with 35% or less.
💡
Conclusion & Impact:Key words: Miocardial viability, FDG-PET (CT), CABG, lower left ventrikular ejection fraction, preoperative surgery endication decision.
🔬Design:Research Article
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Özet

Objective: The aim of our study was to evaluate clinical value and accuracy of Fludeoxyglucose Cardiac Positron Emission Tomography Computerized Tomography as an alternative tool for myocardial viability determination prior to coronary revascularization decision in lower left ventricular ejection fraction patients. Materials and Methods: Between the dates of 01.01.2010 and 10.07.2019, 191 consecutive patients (mean age 64±9.1 years) underwent coronary artery bypass graft operations with severe left ventricular ejection fraction dysfunction with 35% or less. These impaired left ventricular ejection fraction patients were calculated as 4.4%. Myocardial viability was studied by Fludeoxyglucose Cardiac Positron Emission Tomography Computerized Tomography for all cases. Final surgical decision was primarily depended on Fludeoxyglucose Cardiac Positron Emission Tomography Computerized Tomography for the majority of cases. Results: 191 coronary artery bypass graft operations were performed. Perioperative deaths occured in 18 (9.4%) cases. 236 patients with impaired left ventricular ejection fraction and coronary artery disease were evaluated by Fludeoxyglucose Cardiac Positron Emission Tomography Computerized Tomography prior to operation. 191 cases (80.9%) were accepted as canditates for revascularization with multiple viable segments.45 cases (19.1%) presented transmural scar tissue (non-viable) images by Fludeoxyglucose uptake analysis. This group cases were considered to be with non-beneficial results from revascularization. Thus, these patients were referred to medical treatments. Mean number of viable segments on Fludeoxyglucose Cardiac Positron Emission Tomography Computerized Tomography were calculated as 5.2±1.4 for each patient. Conclusions: The presence of myocardial viability is crucial to define reasonable canditates for revascularization in cases with lower left ventricular ejection fraction. Among other preoperative viability detection techniques such as echocardiography and myocardial perfusion scintigraphies, Fludeoxyglucose Cardiac Positron Emission Tomography Computerized Tomography is accepted as the ‘Gold Standart’ for segmental analysis on basis of distinguishing scar tissue from viable components. Key words: Miocardial viability, FDG-PET (CT), CABG, lower left ventrikular ejection fraction, preoperative surgery endication decision.

🔖

Cite This Article

TALAY, S., TALAY, N. B. (2020). F18-FDG Cardiac PET/CT: An Alternative Tool for Myocardial Viability Determination Prior to Coronary Revascularization Decision in Severe Ventricular Dysfunction. Acta Medica, Cilt: 51 - Sayı: 1, 21–31. https://ajindex.com/articles/141621

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Mickleborough LL, Maruyama H, Takagi Y, et al. Results of revascularization in patients with severe left ventricular dysfunction. Circulation 1995;92:73-79 [2] Pagano D, Bonser RS, Townend JN, et al. Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure. Heart 1998; 79: 281–88 [3] Pagano D, Townend JN, Littler WA et al. Coronary artery bypass surgery as treatment for ischemic heart failure: the predictive value of viability assessment with quantitative positron emission tomography for symptomatic and functional outcome. J Thorac Cardiovasc Surg 1998;115:791–99 [4] Strauss HW, Miller DD, Wittry MD, et al. Procedure Guideline for Myocardial Perfusion Imaging. J Nucl Med 2008; 36(3):155-61. [5] Klocke FJ, Baird MG, Lorell BH. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging: executive summary—a report of the American College of Cardiology/American Heart Association task force on practice guidelines (ACC/AHA/ASNC committee to revise the 1995 guidelines for the clinical use of cardiac radionuclide imaging). Circulation 2003;108:1404–18. [6] Kennedy JW, Kaiser GC, Fisher LD, et al. Clinical and angiographic predictors of operative mortality from the Collaborative Study in Coronary Artery Surgery (CASS). Circulation 1981;.63:793-02. [7] Passamani E, Davis KB, Gillespie MJ, et al. A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction. N Engl J Med 1985;312:1665-71. [8] Toda K, Mackenzie K, Mehra MR, et al. Revascularization in severe ventricular dysfunction (15% LVEF 30%): a comparison of bypass grafting and percutaneous intervention. Ann Thorac Surg 2002;74: 2082-87. [9] Koepfli P, Hany TF, Wyss CA. CT attenuation correction for myocardial perfusion quantification using a PET/CT hybrid scanner. J Nucl Med 2004;45: 537–42. [10] Bax JJ, Visser FC, Poldermans D. Relationship between preoperative viability and postoperative improvement in LVEF and heart failure symptoms. J Nucl Med 2001;42:79–86 [11] Di Carli MF, Asgarzadie F, Schelbert HR. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 1995;92: 3436-44. [12] Domanski M, Krause-Steinrauf H. The effect of diabetes on outcomes of patient with advenced heart failure in BEST trial. J Am Coll Cardiol 2003; 42:91